JPMorgan sees Indian firms boost outbound M&A to $28.6bn in 2026
JPMorgan notes Indian companies' outbound M&A hit $28.6 bn across 147 deals in 2026, driven by stronger balance sheets and strategic scale ambitions.
Key Takeaways
- Outbound M&A value reached $28.6 bn across 147 deals in 2026, up from $26.8 bn in 2025.
- Sectors driving the trend include pharmaceuticals, industrials and technology services, where scale offers valuation premiums.
- Execution risk remains high as integration complexity and foreign regulatory approvals could delay value realization.
Indian companies are accelerating cross‑border acquisitions, with outbound M&A valued at $28.6 bn across 147 transactions in 2026, according to JPMorgan’s India investment‑banking co‑heads Ravi Shankar and Nitin Maheshwari.
What Happened
JPMorgan reports that Indian firms’ outbound deal flow has risen to 26.8 bn recorded in 2025 despite a lower number of deals (147 vs. 194). The surge is concentrated in pharmaceuticals, industrials and technology services, where companies seek scale to capture valuation premiums. Notable cross‑border transactions cited by JPMorgan include Sun Pharma’s 4.4 bn investment in Shriram Finance.
Financial Analysis & Context
- Deal volume vs. value: While the number of outbound deals fell from 194 to 147, total value rose by $1.8 bn, indicating a shift toward larger, strategic acquisitions.
- Sector impact: Scale‑driven buyers can spread technology spend over a broader revenue base, potentially improving EBITDA margins, though integration costs are not disclosed.
- Inbound contrast: Inbound M&A slipped to 33.3 bn in 2025, but JPMorgan notes a resurgence of interest from multinationals seeking Indian manufacturing capacity.
Key Technology / Policy Context
The outbound trend aligns with a broader global move toward larger, integrated platforms. JPMorgan highlights that markets reward scale, with a handful of mega‑cap firms enjoying multiple‑digit valuation premiums. For Indian exporters, this translates into stronger negotiating power in supply‑chain contracts and better access to foreign currency financing.
Independent Analysis & Key Risks
The appetite for overseas deals reflects healthier balance sheets and confidence in integration capabilities. However, risks include:
- Regulatory hurdles: Foreign antitrust reviews and sector‑specific approvals can delay closures.
- Integration complexity: Cultural and operational mismatches may erode anticipated synergies.
- Currency volatility: Large dollar‑denominated deals expose Indian acquirers to FX risk, especially if rupee depreciation persists.
Overall, the outbound M&A surge signals a strategic pivot toward global scale, but investors should monitor execution risk and macro‑economic headwinds.
Disclaimer: This report is for informational purposes only and does not constitute investment advice.
Sources & References
- View sourceLivemintNews Report
Indian companies ramp up overseas dealmaking amid growth push: JPMorgan
- View sourceTradingViewNews Report
Indian companies ramp up overseas dealmaking amid growth push: JPMorgan
TradeKaizen Markets Desk
Equities & Market Coverage Desk
The TradeKaizen Markets Desk covers Indian equities, index movements, institutional flows, and exchange disclosures from NSE and BSE.